Prognostic Factors in EGFR Mutation‐positive Patients With Bone Metastases from Lung Adenocarcinoma
Although there was no difference in the mean survival time between patients receiving or not receiving bone radiotherapy, the treatment effectively reduced pain and prevented paralysis. As a first-line treatment in EGFR mutation-positive patients, first- or second-generation TKIs followed by third-generation TKIs showed favorable outcomes.
Authors
- Jun Kawashima (ORCID: https://orcid.org/0000-0003-1072-0776)
- Takako Nagai (ORCID: https://orcid.org/0000-0001-6048-7058)
- Eiji Osaka (ORCID: https://orcid.org/0000-0002-3429-2238)
- Akira Kisohara
- Kohei Tagawa
- Toshio Kojima (ORCID: https://orcid.org/0000-0002-8889-7152)
- Shunzo Osaka
- Kazuyoshi Nakanishi (ORCID: https://orcid.org/0000-0001-7497-8667)
- Yoshiaki Tanaka (ORCID: https://orcid.org/0000-0002-9796-0280)
- Ryoma Kaguchi
- Shumei Kan
- Naoki Toda (ORCID: https://orcid.org/0000-0002-9624-8400)
Institutions
- Nihon University (JP)
- Tokyo Women's Medical University (JP)
Publication Details
- Journal
- Cancer Diagnosis & Prognosis
- Published
- 2025-05-03
- DOI
- https://doi.org/10.21873/cdp.10451
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00